You are here

MEDROS, INC.

Company Information
Address
4041 Forest Park Avenue Center for Emerging Technologies
St. Louis, MO 63108 2809
United States



Information

UEI: N/A

# of Employees: N/A


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Establishing Drosophila Tools for Pathway Mapping and Target Identification

    Amount: $150,000.00

    DESCRIPTION (provided by applicant): The pharmaceutical industry is under growing scrutiny due to the high failure rate in the clinic and the exorbitant cost of research resulting in expensive medicat ...

    SBIRPhase I2010Department of Health and Human Services National Institutes of Health
  2. Tunable Insulin Resistance in a Drosophila Model of Diabetes

    Amount: $152,114.00

    DESCRIPTION (provided by applicant): Diabetes has reached epidemic proportions in the United States resulting in expenditures of over 90B per year. The enormity of the potential market inspired many ...

    SBIRPhase I2010Department of Health and Human Services National Institutes of Health
  3. Using Drosophila to Screen p38 Inhibitors Targeted to the Liver as Novel Diabetes

    Amount: $136,313.00

    DESCRIPTION (provided by applicant): Diabetes has reached epidemic proportions in the United States resulting in expenditures of over 90B per year. The enormity of the potential market inspired many ...

    SBIRPhase I2009Department of Health and Human Services National Institutes of Health
  4. Assessing Concentration Levels of Pharmacological Agents in Drosophila

    Amount: $137,071.00

    DESCRIPTION (provided by applicant): The pharmaceutical industry is under mounting pressure to reinvent itself due to high failure rates in the clinic and exorbitant research costs. Larger research an ...

    SBIRPhase I2008Department of Health and Human Services National Institutes of Health
  5. High Throughput Lethality Screen in Drosophila Against Tumor Metastasis

    Amount: $132,480.00

    DESCRIPTION (provided by applicant): Cancer continues to be a growing health issue. Overall five-year survival rates have changed only marginally over the past three decades and success rates in putti ...

    SBIRPhase I2008Department of Health and Human Services National Institutes of Health
  6. High Throughput Drug Screening in Drosophila for Novel Cancer Therapeutics

    Amount: $132,178.00

    DESCRIPTION (provided by applicant): Cancer is a growing problem in this country and in the world. It is the second leading cause of death in this country, accounting for nearly one in four deaths. In ...

    SBIRPhase I2007Department of Health and Human Services National Institutes of Health
  7. High Throughput Drug Screening in Drosophila for Novel Diabetes Therapeutics

    Amount: $164,300.00

    DESCRIPTION (provided by applicant): Diabetes mellitus and related metabolic syndrome represent perhaps the fastest growing major disease market in the developing world. Diabetes has recently been des ...

    STTRPhase I2007Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government